post-marketing surveillance comes up often in conversation and rarely with the context attached. Here we lay out the basics in order, then work through the practical considerations.
Updated 2026-03-29. Numbers and descriptions here follow the published literature rather than marketing material.
Melanotan II is a synthetic peptide analog modeled on alpha-melanocyte-stimulating hormone, a naturally occurring signaling peptide involved in pigmentation. Its structure is a cyclic heptapeptide containing two non-natural substitutions, norleucine at position four and D-phenylalanine at position seven. These modifications resist enzymatic breakdown and extend the molecule's activity relative to the native hormone. The compound binds melanocortin receptors and is studied mainly as a pharmacological tool rather than a therapeutic product. It has never received approval as a medicine in any major jurisdiction.
The compound was developed in the late 1980s and 1990s by academic researchers investigating photoprotection. The rationale held that stimulating melanin production might reduce ultraviolet damage to skin and lower skin cancer risk. Early work examined receptor binding, pigment response, and short-term tolerability in small studies. That program did not produce an approved drug, and formal development stalled after early-phase trials. Whether induced pigmentation confers meaningful photoprotection remains an open question.
Outside regulated medicine, melanotan II circulates through online vendors as a research chemical, often marketed for tanning. Products sold this way vary widely in purity, concentration, and labeling accuracy, and independent testing has documented discrepancies. Published reports describe both pigment effects and adverse reactions, including nausea, flushing, and darkening of existing moles. Long-term safety data are sparse, and no large controlled trial has established a risk profile. Questions about cumulative effects on melanocytes remain unresolved in the literature.
Lyophilised melanotan-2 is supplied as a solid, which is more stable than a solution. The material is hygroscopic, so weighing is done quickly, in low humidity, with the container kept sealed. Reconstitution usually uses water for injection or bacteriostatic water, added down the wall of the vial to limit foaming. A reconstituted solution is held at 2 to 8 °C and kept away from light. Repeated freezing and thawing of the same vial is avoided because ice crystal formation and concentration effects degrade the peptide.
Reversed-phase high-performance liquid chromatography is the routine method for purity assessment. Peptides absorb near 214 nm because of the peptide bond, and a gradient of acetonitrile in water separates the intact peptide from deletion sequences, oxidised products, and earlier-eluting fragments at neutral pH. Electrospray ionisation mass spectrometry provides an orthogonal check: the measured mass must agree with the theoretical value. Amino acid analysis and peptide mapping confirm structure but are used less often. Reference standards remain scarce because the peptide is not described in any pharmacopoeia.
| Property | Value | Notes |
|---|---|---|
| Chemical class | Synthetic cyclic heptapeptide | Belongs to the melanocortin agonist family |
| Key substitutions | Nle4 and D-Phe7 | Improve resistance to enzymatic degradation |
| Molecular formula | C50H69N15O9 | Approximately 1024 g/mol |
| Regulatory status | Not approved as a medicine | Distributed as a research chemical |
| Common synonyms | Melanotan II, MT-II, MT-2 | Spelling varies across sources |
Melanotan-2 is a synthetic peptide designed as an analog of alpha-melanocyte-stimulating hormone, a signaling molecule produced in the pituitary and skin. Its structure is a linear chain of seven amino acids that folds into a ring through an internal lactam bridge joining two side chains. The compound is sometimes written as MT-II or MEL-2 in informal and commercial contexts. It belongs to the melanocortin peptide family, a group of short signaling molecules that share a conserved core sequence recognized by melanocortin receptors.
Two structural changes distinguish the synthetic peptide from the natural hormone. A norleucine residue replaces methionine at one position, and a D-configured phenylalanine replaces the natural L-form at another. Both substitutions slow enzymatic breakdown, which extends the molecule's persistence relative to the parent hormone. The lactam bridge further constrains the backbone into a stable conformation. These features are standard design strategies in peptide chemistry and are not unique to this compound; they appear across many research peptides built for improved stability.
Melanotan-2 has not received marketing authorisation from major regulatory agencies for any therapeutic indication. Several jurisdictions classify it as a prescription-only medicine or a controlled substance when supplied for human use. Because approved products do not exist, material sold online usually sits outside pharmaceutical supply chains and formal quality oversight. Regulators have issued public notices describing the compound as unapproved. Enforcement varies, and the legal position differs between countries, which complicates any single general statement about its status.
Scientific discussion of Melanotan-2 spans pharmacology, dermatology, and public-health literature. Laboratory studies examine its receptor binding and cellular effects, while clinical reports describe outcomes observed after unregulated use. These two bodies of work differ in rigour and intent. Peer-reviewed trials of the compound as a medicine are limited, so much of the available information comes from case reports and surveillance data. Authors frequently note the gap between experimental findings and real-world use.
Pharmacologically, melanotan-2 behaves as a non-selective agonist across the melanocortin receptor family. Binding at MC1R on dermal melanocytes promotes eumelanin synthesis, which underlies the tanning response described in early human work. Activity at the centrally expressed MC4R receptor is associated with reported effects on appetite and erectile function. Because the peptide does not discriminate strongly among receptor subtypes, attributing any single observed effect to one receptor pathway is generally not possible without selective antagonists or receptor knockout models.
Research interest has centred on photoprotection and pigmentation, with a smaller body of work on appetite and sexual function. Published human data remain limited to small, frequently uncontrolled studies, and the compound has never received marketing approval from a national medicines regulator. Most laboratory work treats it as a pharmacological tool for probing melanocortin signalling in cell culture or animal models. Whether pigmentation changes observed in people translate into measurable protection against ultraviolet-induced DNA damage remains an open question.
They used adult rats as the subject of their experiment and added amino acids synthesised from isotopic ammonia to their diet. When these diets were applied in nitrogen equilibrium it was found they were incorporated into tissue proteins at an intensive and rapid rate. There was also evidence of chemical transformation as heavy nitrogen was present in amino acids, which were isolated from protein, following ingestion. This chemical transformation was similar to that demonstrated in the fatty acids of his previous experiments on intermediary metabolism. The results of the experiment revealed that body proteins are in a continuous and dynamic state of synthesis and degradation. Schoenheimer and Rittenberg were responsible for discovering that body constituents were in a state of constant chemical renewal, as they were previously believed to be in a static state. Experiments on the metabolism of amino acids, fatty acids, and excretory products are used to support and demonstrate this concept of metabolic "regeneration". These molecules go through a process of replacement and interchange in the body tissue, as well as other transformations and fundamental chemical reactions. This method of isotope labelling molecules enabled Schoenheimer and his colleagues to investigate various issues in intermediary metabolism. By the late 1930s, Schoenheimer's work had contributed to the rising interest in intermediary metabolism and the isotope method.
The biosynthesis of caffeine is an example of convergent evolution among different species. Fischer's original synthesis of caffeine from 1895 began with condensation of 1,3-dimethylurea and malonic acid to form N,N'-dimethylbarbituric acid, followed by several steps of elaboration to construct the five-membered ring and add the third methyl group. Industrially, caffeine is synthesized from urea and chloroacetic acid. A range of alternative processes are also possible. Most processes for synthesizing caffeine are old, having been patented between the 1940s and the 1960s. The synthesis of caffeine is inexpensive.
=== Tissue engineering === The ability of SHG to image specific molecules can reveal the structure of a certain tissue one material at a time, and at various scales (from macro to micro) using microscopy. For instance, the collagen (type I) is specifically imaged from the extracellular matrix (ECM) of cells, or when it serves as a scaffold or conjonctive material in tissues. SHG also reveals fibroin in silk, myosin in muscles and biosynthetized cellulose. All of this imaging capability can be used to design artificials tissues, by targeting specific points of the tissue : SHG can indeed quantitatively measure some orientations, and material quantity and arrangement. Also, SHG coupled to other multiphoton techniques can serve to monitor the development of engineered tissues, when the sample is relatively thin however. Of course, they can finally be used as a quality control of the fabricated tissues.
Sources: en.wikipedia.org
=== Morphological data === The fact that substitution models can be used to analyze any biological alphabet has made it possible to develop models of evolution for phenotypic datasets (e.g., morphological and behavioural traits). Typically, "0" is. used to indicate the absence of a trait and "1" is used to indicate the presence of a trait, although it is also possible to score characters using multiple states. Using this framework, we might encode a set of phenotypes as binary strings (this could be generalized to k-state strings for characters with more than two states) before analyses using an appropriate mode. This can be illustrated using a "toy" example: we can use a binary alphabet to score the following phenotypic traits "has feathers", "lays eggs", "has fur", "is warm-blooded", and "capable of powered flight". In this toy example hummingbirds would have sequence 11011 (most other birds would have the same string), ostriches would have the sequence 11010, cattle (and most other land mammals) would have 00110, and bats would have 00111. The likelihood of a phylogenetic tree can then be calculated using those binary sequences and an appropriate substitution model. The existence of these morphological models make it possible to analyze data matrices with fossil taxa, either using the morphological data alone or a combination of morphological and molecular data (with the latter scored as missing data for the fossil taxa).
In August 1954, in support of the French navy and the merchant navy, the U.S. Navy launched Operation Passage to Freedom and sent hundreds of ships, including USS Montague, in order to evacuate non-communist—especially Catholic—Vietnamese refugees from North Vietnam following the July 20, 1954, armistice and partition of Vietnam. Up to 1 million Vietnamese civilians were transported from North to South during this period, with around one-tenth of that number moving in the opposite direction.
The three substrates of this enzyme are (R)-β-alanopine, oxidised nicotinamide adenine dinucleotide (NAD+), and water. Its products are β-alanine, reduced NADH, pyruvic acid and a proton. β-alanopine is a type of opine. This enzyme belongs to the family of oxidoreductases, specifically those acting on the CH-NH group of donors with NAD+ or NADP+ as acceptor. The systematic name of this enzyme class is N-(D-1-carboxyethyl)-beta-alanine:NAD+ oxidoreductase (beta-alanine-forming).
Sources: en.wikipedia.org
Ty Tennant as Peter Pan (season 2), the current incarnation of the Greek god Pan, who is determined to recapture the characters of his story world so he can return to Neverland Reece Ritchie as Benedict Hale (season 2), Virkam's immediate successor and the active Librarian of 1847-1857, who accidentally imprisoned himself in an artifact courtesy of Anya after conspiring to use magic for his own gain Jack Cunningham-Nuttall as King Arthur (season 2), as he was before he became the ruler of Camelot
In contrast, some infectious agents such as the Feline leukemia virus, are able to withstand immune responses and are capable of achieving long-term residence within an individual host, whilst also retaining the ability to spread into successive hosts. Virulence refers to the ability of an organism to invade a host and cause disease. Virulence factors are molecules that enable bacteria to attach to and invade the host's cells. These factors can be secreted, featured on the membrane, or located inside the cell (cytosolic). Cytosolic factors help bacteria rapidly adapt their metabolic, physical, and structural characteristics. Membrane-bound factors help bacteria adhere to the host and avoid detection by the host's immune system. Secreted factors assist bacteria to overcome the body's innate and adaptive immune defenses. In extracellular threats, secreted factors work together to destroy host cells.
N,N′-Dicyclohexylcarbodiimide (DCC or DCCD) is an organic compound with the chemical formula (C6H11N)2C. It is a waxy white solid with a sweet odor. Its primary use is to couple amino acids during artificial peptide synthesis. The low melting point of this material allows it to be melted for easy handling. It is highly soluble in dichloromethane, tetrahydrofuran, acetonitrile and dimethylformamide, but insoluble in water.
Sources: en.wikipedia.org
It is a synthetic cyclic peptide designed as an analog of alpha-melanocyte-stimulating hormone. It acts on melanocortin receptors and is best known from research into pigmentation. It is not an approved pharmaceutical product.
No regulatory agency has approved it for any indication. It is encountered as a research chemical sold outside pharmaceutical supply chains. Products marketed this way are not subject to the manufacturing and labeling requirements that apply to approved drugs.
Reports describe increased skin pigmentation as well as side effects such as nausea, flushing, and changes to existing moles. Much of the evidence comes from small studies and case reports rather than large trials. The long-term safety profile is therefore uncertain.
Low temperature slows hydrolysis and oxidation, the two main routes by which the peptide backbone and side chains are modified. A lyophilised powder stored at −20 °C is more stable than one kept at room temperature, and once the material is dissolved the degradation rate rises, making refrigeration more important.